CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 840 enrolled
Drug / intervention
Observationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02451904
NCT02451904N/ACompleted

Microvascular and Metabolic Dysregulation in the Pathogenesis of Severe and Cerebral Malaria Investigated Through Host Metabolomics

University of Oxford·observational·Posted May 22, 2015·Updated Jun 20, 2018

In Brief

An observational study evaluating Observation for Severe Malaria. Completed, enrolled 840 participants across 1 site.

Detailed Summary

* The aim is to describe disease mechanisms of severe and cerebral malaria and identify new targets for adjunctive therapies. * Despite treatment between 10-30% of patients with severe malaria die. * Metabolic acidosis and cerebral malaria are major complications associated with mortality across all age groups. Still, their underlying pathogenesis remains incompletely understood. * Using a metabolomics approach, this study aims to characterise the spectrum of acids accumulating during acidosis, and investigate patterns of metabolic dysregulation associated with coma and seizures.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSevere Malaria
CountriesBangladesh

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 22, 2015
Enrollment StartJun 1, 2015
Primary CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 11.1 years ago

Interventions

Observationother